Matches in Nanopublications for { <http://bio2rdf.org/drugbank_resource:DB00864_DB01319> ?p ?o ?g. }
Showing items 1 to 4 of
4
with 100 items per page.
- drugbank_resource:DB00864_DB01319 type drugbank_vocabulary:Drug-Drug-Interaction assertion.
- drugbank_resource:DB00864_DB01319 label "DDI between Tacrolimus and Fosamprenavir - The protease inhibitor, Fosamprenavir, may increase the blood concentration of Tacrolimus. Monitor for changes in the therapeutic/toxic effects of Tacrolimus if Fosamprenavir therapy is initiated, discontinued or altered. [drugbank_resource:DB00864_DB01319]" assertion.
- drugbank_resource:DB00864_DB01319 identifier "drugbank_resource:DB00864_DB01319" assertion.
- drugbank_resource:DB00864_DB01319 title "DDI between Tacrolimus and Fosamprenavir - The protease inhibitor, Fosamprenavir, may increase the blood concentration of Tacrolimus. Monitor for changes in the therapeutic/toxic effects of Tacrolimus if Fosamprenavir therapy is initiated, discontinued or altered." assertion.